Investigación / Grupos de investigación

Grupo  3

Genética y Clínica de las Neoplasias Hematológicas y el Trasplante Hematopoyético

Publicaciones (589)

  • Rubia, JD; Gonzalez, B; Cruz-Jentoft, AJ; Iglesias, L; Jarque, I; Persona, EP; Lluch, R; Marrero, C; Zudaire, M; Gironella, M; Hernandez-Rivas, JA; Arnan, M; Olivier, C; Encinas, C; Soler, JA; Payer, AR; Casado, A; Fernandez, P; Vilanova, D; Bonanad, S.

    Geriatric assessment in hematology scale predicts treatment tolerability in older patients diagnosed with hematological malignancies: The RETROGAH study

    Journal of Geriatric Oncology. 2023; 14(1): Nº de citas: 10 [doi:10.1016/j.jgo.2022.10.016]

  • Colino, CG; Catalan, MA; Honrubia, AM; Acosta, MJO; Abos, MG; Ribelles, AJ; Valero, JMV.

    Adolescent cancer care: What has changed in Spain in the past decade?

    ANALES DE PEDIATRIA. 2023; 98(2): 129-135 [doi:10.1016/j.anpedi.2022.09.012]

  • Andres-Zayas, C; Suarez-Gonzalez, J; Chicano-Lavilla, M; Oreiro, MB; Rodriguez-Macias, G; Lopez, PF; Prendes, SO; Royuela, GO; Ramirez, PG; Salgado, RN; Gomez-Centurion, I; Munoz, DC; Muniz, P; Kwon, M; Diez-Martin, JL; Buno, I; Martinez-Laperche, C.

    Novel Candidate loci and Pathogenic Germline Variants Involved in Familial Hematological Malignancies Revealed by Whole-Exome Sequencing

    Cancers. 2023; 15(3): [doi:10.3390/cancers15030944]

  • Gonzalez-Lopez, TJ; Barez, A; Bernardo-Gutierrez, A; Bernat, S; Canaro-Hirnyk, M; Entrena-Urena, L; Fernandez-Fuertes, F; de Castro, JMG; Jimenez-Barcenas, R; Pascual-Izquierdo, C; Sanchez-Gonzalez, B; Jarque, I.

    Recommendations on the Management of Patients with Immune Thrombocytopenia (ITP) in the Context of SARS-CoV-2 Infection and Vaccination: Consensus Guidelines from a Spanish ITP Expert Group

    Infectious Diseases and Therapy. 2023; 12(2): 303-315 Nº de citas: 6 [doi:10.1007/s40121-022-00745-2]

  • Martinez, C; de Haro, ME; Romero, S; Gutierrez, A; Domingo-Domenech, E; Gonzalez-Rodriguez, AP; Zeberio, I; Martinez-Badas, MP; Rodriguez-Izquierdo, A; Carpio, C; Bastos-Oreiro, M; Hernandez-Rivas, JA; Vallansot, R; Kelleher, N; Diaz-Galvez, FJ; Torrado, T; Pereira, A; Garcia-Sanz, R.

    Impact of pre- and/or post-autologous stem cell transplantation exposure to brentuximab vedotin on survival outcomes in patients with high-risk Hodgkin lymphoma

    ANNALS OF HEMATOLOGY. 2023; 102(2): 429-437 Nº de citas: 6 [doi:10.1007/s00277-022-05011-6]

  • Ortuzar, A; Fox, ML; Vera, JA; Vizcaya, AL; Sanchez, AM; Calatayud, IL; Carbonell, S; Alvarez-Larran, A; Serna, RM; Buades, JEM; Cervantes, KQ; Hellin, AM; Dominguez, AB; Navarro, GC; Sansaloni, AC; Fernandez, LG; Linares, CM; Kabat, MG; Lopez, RP; Rodriguez, AF; Bilbao, CM; Rodriguez, MTC; Diaz, A; Duran, MA; Tomas, MS; Garcia-Gutierrez, V; Mazo, EM; Hernandez-Boluda, JC; Segura, A; Raya, JM; Elorza, BN; Osorio, S.

    Philadelphia-negative chronic myeloproliferative neoplasm follow-up: when the phone rings. Changes during the COVID-19 pandemic and patient satisfaction. Experience in 30 health centers in Spain

    ANNALS OF HEMATOLOGY. 2023; 102(2): 447-456 Nº de citas: 2 [doi:10.1007/s00277-022-05044-x]

  • Muntanola, A; Mozas, P; Mercadal, S; Huguet, M; Bobillo, S; Bastos-Oreiro, M; Jimenez-Ubieto, A; Rovira, J; Rivero, A; Tolosa, C; Luizaga, L; de Villambrosia, SG; Novelli, S; Caballero, D; Salar, A; Alonso-Alvarez, S; Magnano, L; Gutierrez, NC; Sancho, JM; Lopez-Guillermo, A.

    Early progression in follicular lymphoma in the absence of histological transformation or high-risk Follicular Lymphoma International Prognostic Index still has a favourable outcome

    BRITISH JOURNAL OF HAEMATOLOGY. 2023; 200(3): 306-314 Nº de citas: 9 [doi:10.1111/bjh.18522]

  • Cruz, D; Rodriguez-Romanos, R; Gonzalez-Bartulos, M; Garcia-Cadenas, I; de la Camara, R; Heras, I; Buno, I; Santos, N; Lloveras, N; Velarde, P; Tuset, E; Martinez, C; Gonzalez, M; Sanz, GF; Ferra, C; Sampol, A; Coll, R; Perez-Simon, JA; Lopez-Jimenez, J; Jurado, M; Gallardo, D.

    LAG3 genotype of the donor and clinical outcome after allogeneic transplantation from HLA-identical sibling donors

    Frontiers in Immunology. 2023; 14: Nº de citas: 3 [doi:10.3389/fimmu.2023.1066393]

  • Kwon, M; Iacoboni, G; Reguera, JL; Corral, LL; Morales, RH; Ortiz-Maldonado, V; Guerreiro, M; Caballero, AC; Dominguez, MLG; Pina, JMS; Mussetti, A; Sancho, JM; Bastos-Oreiro, M; Catala, E; Delgado, J; Henriquez, HL; Sanz, J; Calbacho, M; Bailen, R; Carpio, C; Ribera, JM; Sureda, A; Briones, J; Hernandez-Boluda, JC; Cebrian, NM; Martin, JLD; Martin, A; Barba, P.

    Axicabtagene ciloleucel compared to tisagenlecleucel for the treatment of aggressive B-cell lymphoma

    HAEMATOLOGICA. 2023; 108(1): 110-121 Nº de citas: 91 [doi:10.3324/haematol.2022.280805]

  • Estirado, AD; Garcia, GS; Aragones, JH; Colino, CG; Seoane-Reula, E; Fernandez, CM.

    Outcomes and impact of multidisciplinary team care on immunologic and hemato-oncologic pediatric patients

    ALLERGOLOGIA ET IMMUNOPATHOLOGIA. 2023; 51(1): 154-158 Nº de citas: 3 [doi:10.15586/aei.v51i1.627]

  • Porwit, A; Bene, MC; Duetz, C; Matarraz, S; Oelschlaegel, U; Westers, TM; Wagner-Ballon, O; Kordasti, S; Valent, P; Preijers, F; Alhan, C; Bellos, F; Bettelheim, P; Burbury, K; Chapuis, N; Cremers, E; Della Porta, MG; Dunlop, A; Eidenschink-Brodersen, L; Font, P; Fontenay, M; Hobo, W; Ireland, R; Johansson, U; Loken, MR; Ogata, K; Orfao, A; Psarra, K; Saft, L; Subira, D; te Marvelde, J; Wells, DA; van der Velden, VHJ; Kern, W; van de Loosdrecht, AA.

    Multiparameter flow cytometry in the evaluation of myelodysplasia: Analytical issues Recommendations from the European LeukemiaNet/International Myelodysplastic Syndrome Flow Cytometry Working Group

    CYTOMETRY PART B-CLINICAL CYTOMETRY. 2023; 104(1): 27-50 Nº de citas: 26 [doi:10.1002/cyto.b.22108]

  • Santoro, N; Mooyaart, JE; Devillier, R; Koc, Y; Vydra, J; Castagna, L; Gulbas, Z; Martin, JD; Araujo, MC; Kulagin, A; Arat, M; Arroyo, CH; Martelli, MP; Di Ianni, M; Hoogenboom, JD; de Wreede, LC; Ruggeri, A; Chabannon, C.

    Donor lymphocyte infusions after haploidentical stem cell transplantation with PTCY: A study on behalf of the EBMT cellular therapy & immunobiology working party

    BONE MARROW TRANSPLANTATION. 2023; 58(1): 54-60 Nº de citas: 21 [doi:10.1038/s41409-022-01839-8]

  • van der Velden, VHJ; Preijers, F; Johansson, U; Westers, TM; Dunlop, A; Porwit, A; Bene, MC; Valent, P; te Marvelde, J; Wagner-Ballon, O; Oelschlaegel, U; Saft, L; Kordasti, S; Ireland, R; Cremers, E; Alhan, C; Duetz, C; Hobo, W; Chapuis, N; Fontenay, M; Bettelheim, P; Eidenshink-Brodersen, L; Font, P; Loken, MR; Matarraz, S; Ogata, K; Orfao, A; Psarra, K; Subira, D; Wells, DA; Della Porta, MG; Burbury, K; Bellos, F; Weiss, E; Kern, W; van de Loosdrecht, A.

    Flow cytometric analysis of myelodysplasia: Pre-analytical and technical issues-Recommendations from the European LeukemiaNet

    CYTOMETRY PART B-CLINICAL CYTOMETRY. 2023; 104(1): 15-26 Nº de citas: 31 [doi:10.1002/cyto.b.22046]

  • Loosdrecht, AA; Kern, W; Porwit, A; Valent, P; Kordasti, S; Cremers, E; Alhan, C; Duetz, C; Dunlop, A; Hobo, W; Preijers, F; Wagner-Ballon, O; Chapuis, N; Fontenay, M; Bettelheim, P; Eidenschink-Brodersen, L; Font, P; Johansson, U; Loken, MR; Marvelde, JG; Matarraz, S; Ogata, K; Oelschlaegel, U; Orfao, A; Psarra, K; Subira, D; Wells, DA; Bene, MC; Della Porta, MG; Burbury, K; Bellos, F; van der Velden, VHJ; Westers, TM; Saft, L; Ireland, R.

    Clinical application of flow cytometry in patients with unexplained cytopenia and suspected myelodysplastic syndrome: A report of the European LeukemiaNet International MDS-Flow Cytometry Working Group

    CYTOMETRY PART B-CLINICAL CYTOMETRY. 2023; 104(1): 77-86 Nº de citas: 23 [doi:10.1002/cyto.b.22044]

  • Izquierdo CP; Mingot-Castellano ME; Fuentes AEK; García-Arroba Peinado J; Cid J; Jimenez MM; Valcarcel D; Gómez-Seguí I; de la Rubia J; Martin P; Goterris R; Hernández L; Tallón I; Varea S; Fernández M; García-Muñoz N; Vara M; Zarzoso MF; García-Candel F; Paciello ML; García-García I; Zalba S; Campuzano V; Gala JM; Estévez JV; Jiménez GM; López Lorenzo JL; Arias EG; Freiría C; Solé M; Ávila Idrovo LF; Hernández Castellet JC; Cruz N; Lavilla E; Pérez-Montaña A; Atucha JA; Moreno Beltrán ME; Moreno Macías JR; Salinas R; Del Rio-Garma J.

    Real-world effectiveness of caplacizumab vs the standard of care in immune thrombotic thrombocytopenic purpura

    Blood Advances. 2022; 6(24): 6219-6227 Nº de citas: 31 [doi:10.1182/bloodadvances.2022008028]

  • Villalba, A; Gonzalez-Rodriguez, AP; Arzuaga-Mendez, J; Puig, N; Arnao, M; Arguinano, JM; Jimenez, M; Canet, M; Teruel, AI; Sola, M; Diaz, FJ; Encinas, C; Garcia, A; Rosinol, L; Suarez, A; Gonzalez, MS; Izquierdo, I; Hernandez, MT; Infante, MS; Sanchez, MJ; Sampol, A; de la Rubia, J.

    Single versus tandem autologous stem-cell transplantation in patients with newly diagnosed multiple myeloma and high-risk cytogenetics. A retrospective, open-label study of the PETHEMA/Spanish Myeloma Group (GEM)

    LEUKEMIA & LYMPHOMA. 2022; 63(14): 3438-3447 Nº de citas: 8 [doi:10.1080/10428194.2022.2123229]

  • Buenestado-Serrano S; Recio R; Sola Campoy PJ; Catalán P; Folgueira MD; Villa J; Muñoz Gallego I; de la Cueva VM; Meléndez MA; Andrés Zayas C; Losa-García JE; Goyanes MJ; Fraile Torres A; Von Wermitz A; Fradejas-Villajos I; Del Arco C; Campelo-Gutiérrez C; González Bodi S; López-Wolf D; Iglesias-Franco H; Pérez-Lago L; Arce Arnaez A; Rodriguez Baena E; Ordobas Gavin M; Muñoz P; Delgado R; Cardeñoso L; Viedma E; García de Viedma D.

    First confirmation of importation and transmission in Spain of the newly identified SARS-CoV-2 B.1.1.7 variant.

    Enfermedades Infecciosas Y Microbiologia Clinica (english Ed.). 2022; 40(10): 546-549 [doi:10.1016/j.eimce.2021.02.013]

  • Barbui, T; Carobbio, A; Ghirardi, A; Iurlo, A; Sobas, MA; Elli, EM; Rumi, E; De Stefano, V; Lunghi, F; Marchetti, M; Daffini, R; Kabat, MG; Cuevas, B; Fox, ML; Andrade-Campos, MM; Palandri, F; Guglielmelli, P; Benevolo, G; Harrison, C; Foncillas, MA; Bonifacio, M; Alvarez-Larran, A; Kiladjian, JJ; Calderon, EB; Patriarca, A; Cervantes, KQ; Griesshammer, M; Garcia-Gutierrez, V; Sanchez, AM; Mazo, EM; Carli, G; Hernandez-Boluda, JC; Osorio, S; Carreno-Tarragona, G; Serrano, MS; Kusec, R; Elorza, BN; Angona, A; Cirici, BX; Abadia, EL; Koschmieder, S; Cattaneo, D; Bucelli, C; Cichocka, E; de Nalecz, AK; Cavalca, F; Borsani, O; Betti, S; Bellini, M; Curto-Garcia, N; Rambaldi, A; Vannucchi, AM.

    Determinants of early triage for hospitalization in myeloproliferative neoplasm (MPN) patients with COVID-19

    AMERICAN JOURNAL OF HEMATOLOGY. 2022; 97(12): 470-473 Nº de citas: 8 [doi:10.1002/ajh.26732]